Corteva, Inc. $CTVA Shares Sold by Victory Capital Management Inc.

Victory Capital Management Inc. decreased its position in shares of Corteva, Inc. (NYSE:CTVA) by 27.7% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 214,775 shares of the company’s stock after selling 82,461 shares during the quarter. Victory Capital Management Inc.’s holdings in Corteva were worth $14,525,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Total Investment Management Inc. purchased a new position in Corteva during the 2nd quarter worth approximately $27,000. Activest Wealth Management lifted its stake in Corteva by 118.3% in the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after buying an additional 200 shares during the last quarter. True Wealth Design LLC boosted its holdings in shares of Corteva by 209.5% in the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock valued at $26,000 after acquiring an additional 264 shares during the period. Twin Peaks Wealth Advisors LLC acquired a new stake in shares of Corteva in the second quarter valued at approximately $29,000. Finally, Redmont Wealth Advisors LLC purchased a new position in shares of Corteva during the third quarter worth approximately $29,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Stock Performance

NYSE:CTVA opened at $76.30 on Wednesday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. The firm has a market cap of $51.31 billion, a price-to-earnings ratio of 48.29, a price-to-earnings-growth ratio of 2.68 and a beta of 0.72. The firm’s fifty day moving average price is $73.40 and its 200 day moving average price is $69.06. Corteva, Inc. has a 1-year low of $53.40 and a 1-year high of $80.90.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting analysts’ consensus estimates of $0.22. The company had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. Corteva’s quarterly revenue was down 1.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts expect that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be given a $0.18 dividend. The ex-dividend date is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio (DPR) is presently 45.57%.

Insiders Place Their Bets

In other Corteva news, insider Brian Titus sold 8,311 shares of the business’s stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the transaction, the insider owned 8,090 shares in the company, valued at approximately $619,289.50. The trade was a 50.67% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 0.15% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently commented on CTVA shares. CICC Research upped their price target on shares of Corteva from $70.00 to $80.00 and gave the company an “outperform” rating in a research report on Wednesday, February 11th. The Goldman Sachs Group reissued a “buy” rating and set a $88.00 price objective on shares of Corteva in a research report on Thursday, February 5th. Argus upgraded shares of Corteva to a “strong-buy” rating in a research note on Friday, January 16th. JPMorgan Chase & Co. downgraded shares of Corteva from an “overweight” rating to a “neutral” rating and increased their target price for the stock from $75.00 to $77.00 in a research note on Thursday, February 5th. Finally, Zacks Research lowered Corteva from a “strong-buy” rating to a “hold” rating in a report on Friday, February 20th. One analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $82.90.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.